Optimizing Biomarker Testing in Your Practice: Leveraging In-House Testing Strategies - Episode 11

Mitigating Socioeconomic Disparities Through Decentralized Testing: Overcoming Barriers to Access and Equity

,

Panelists discuss how decentralizing testing can address socioeconomic disparities by improving access to diagnostics for underserved populations. In-house testing reduces barriers like transportation challenges, lack of insurance, and limited availability of specialized tests, ensuring timely, equitable health care for all communities.

EP. 1: Key Considerations When Ordering Biomarker Testing
EP. 2: The Importance of Broad Biomarker Testing: Uncovering Actionable Targets Across Tumor Types
EP. 3: When to Choose Narrow Panel Testing Over Comprehensive Testing in Biomarker Analysis
EP. 4: Centralized vs Decentralized Biomarker Testing: Workflow, Control, and Collaboration Insights
EP. 5: In-House Comprehensive Genomic Profiling: Expert Insight Into Balancing Benefits and Challenges
EP. 6: Implementing In-House Biomarker Testing: Rationale and Key Considerations
EP. 7: Optimizing In-House Testing: Enhancing Efficiency for Timely Results and Treatment Decisions
EP. 8: Enhancing Multidisciplinary Coordination and Treatment Planning Through In-House Testing
EP. 9: Impact of In-House Testing on Improved Cancer Care: Timely Decisions and Enhanced Treatment Accuracy
EP. 10: Decentralization of Biomarker Testing: Expanding Access to Targeted Therapies and Clinical Trials in Underserved Populations
Now Viewing
EP. 11: Mitigating Socioeconomic Disparities Through Decentralized Testing: Overcoming Barriers to Access and Equity

Video series above is prompted by the following:

  • Are there other socioeconomic disparities that exist where test decentralization might be helpful?
  • Discuss how in-house testing can mitigate disparities caused by socioeconomic factors, including transportation, insurance coverage, and limited availability of specialized tests in certain regions.